AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
15.33
-0.08 (-0.52%)
At close: Nov 3, 2026, 4:00 PM EST
15.25
-0.08 (-0.52%)
Pre-market: Nov 4, 2026, 4:32 AM EST
AVITA Medical Revenue
AVITA Medical had revenue of $21.70M in the quarter ending June 30, 2026, with 17.83% growth. This brings the company's total for the last twelve months to $75.63M, up 1.00% year-over-year. In the year 2025, AVITA Medical had annual revenue of $71.61M with 11.45% growth. That makes AVITA Medical the 24,838th largest company in the world by revenue and 3,471st in the United States.
Revenue (ttm)
$75.63M
Revenue Growth
+1.00%
P/S Ratio
6.27
Revenue / Employee
$334,650
Employees
226
Market Cap
474.11M
Revenue by Geography
- United States 68.79M 96.1%
- Japan 2.09M 2.9%
- United Kingdom 486.00K 0.7%
- Australia 200.00K 0.3%
- European Union 49.00K 0.1%
Fiscal year ended Dec 31, 2025 See the full AVITA Medical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.61M | 7.36M | 11.45% |
| Dec 31, 2024 | 64.25M | 14.11M | 28.14% |
| Dec 31, 2023 | 50.14M | 15.72M | 45.68% |
| Dec 31, 2022 | 34.42M | 5.19M | 17.75% |
| Jun 30, 2021 | 29.23M | 14.97M | 104.95% |
| Jun 30, 2020 | 14.26M | 8.79M | 160.56% |
| Jun 30, 2019 | 5.47M | 4.55M | 489.24% |
| Jun 30, 2018 | 929.00K | 234.89K | 33.84% |
| Jun 30, 2017 | 694.11K | -52.35K | -7.01% |
| Jun 30, 2016 | 746.46K | -188.72K | -20.18% |
| Jun 30, 2015 | 935.18K | -2.16M | -69.75% |
| Jun 30, 2014 | 3.09M | -611.36K | -16.51% |
| Jun 30, 2013 | 3.70M | -1.59M | -30.06% |
| Jun 30, 2012 | 5.29M | 553.99K | 11.69% |
| Jun 30, 2011 | 4.74M | 1.45M | 44.21% |
| Jun 30, 2010 | 3.29M | 643.61K | 24.34% |
| Jun 30, 2009 | 2.64M | 768.38K | 40.97% |
| Jun 30, 2008 | 1.88M | 540.04K | 40.44% |
| Jun 30, 2007 | 1.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tactile Systems Technology | 356.42M |
| Cerus | 226.57M |
| NeuroPace | 106.99M |
| Delcath Systems | 95.42M |
| Sight Sciences | 83.38M |
| 908 Devices | 60.84M |
| BrainsWay | 60.70M |
| Shoulder Innovations | 60.06M |
RCEL News
- 14 days ago - AVITA Medical to Announce Third Quarter 2026 Financial Results - GlobeNewsWire
- 22 days ago - Avita Medical price target raised to $15 from $11 at BTIG - TheFly
- 6 weeks ago - AVITA Medical Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 2 months ago - AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference - GlobeNewsWire
- 2 months ago - Avita Medical price target raised to $12 from $8 at Lake Street - TheFly
- 2 months ago - Avita Medical price target raised to $14 from $12 at TD Cowen - TheFly
- 2 months ago - Avita Medical price target raised to $11 from $7 at BTIG - TheFly
- 2 months ago - AVITA Medical Transcript: KOL event - Transcripts